- Stanley JR. Pemphigus. In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, eds. Dermatology in General Medicine. New York: McGraw-Hill, 1998: 654–666.
- Lee AN, Werth VP. Activation of autoimmunity following use of immunostimulatory herbal supplements. Arch Dermatol 2004;140: 723–727.
- Stavropoulos PG, Kostakis PG, Papakonstantinou AM, Panagiotopoulos A, Petridis AD. Coexistence of psoriasis and pemphigus after enalapril intake. Dermatology 2003;207: 336–337.
- Shapiro M, Jimenez S, Werth VP. Pemphigus vulgaris induced by d-penicillamine therapy in a patient with systemic sclerosis. J Am Acad Dermatol 2000;42: 297–299.
- Orion E, Matz H, Wolf R. Pemphigus vulgaris induced by radiotherapy. J Eur Acad Dermatol Venereol 2004;18: 508–509.
- Shieh S, Fang YV, Becker JL, Holm A, Beutner EH, Helm TN. Pemphigus, pregnancy, and plasmapheresis. Cutis 2004;73: 327–329.
- Jain R, Dogra S, Sandhu K, Handa S, Kumar B. Coexistence of vitiligo and pemphigus vulgaris in an Indian patient. Pediatr Dermatol 2003;20: 369–370.
- Nanda A, Kapoor MM, Dvorak R, Al-Sabah H, Alsaleh QA. Coexistence of pemphigus vulgaris with systemic lupus erythematosus. Int J Dermatol 2004;43: 393–394.
- Herron MD, Kohan DE, Hansen CD. Minimal change nephropathy associated with pemphigus vulgaris: a new relationship? J Am Acad Dermatol 2004;50: 645.
- Patten SF, Dijkstra JW. Association of pemphigus and autoimmune disease with malignancy or thymoma. Int J Dermatol 1994;33: 836–842.
- Beuther EH, Jordan RE. Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining. Proc Soc Exp Biol Med 1964;117: 505–510.
- Liu Z, Li N, Diaz LA. Immunopathological mechanisms of acantholysis in pemphigus vulgaris: an explanation by ultrastructural observations. J Invest Dermatol 2004;122: XIII–XIV.
- Karpati S, Amagai M, Prussick R, Cehrs K, Stanley JR. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is located within keratinocyte desmosomes. J Cell Biol 1993;122: 409–415.
- Jain R, Kumar B. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy. J Dermatol 2003;30: 713–718.
- Liu V, Mackool BT. Mycophenolate in dermatology. J Dermatolog Treat 2003;14: 203–211.
- Dupuy A, Viguier M, Bedane C, Cordoliani F, Blaise S, Aucouturier F, Bonnetblanc JM, Morel P, Dubertret L, Bachelez H. Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody). Arch Dermatol 2004;140: 91–96.
- Gach JE, Ilchyshyn A. Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris. Clin Exp Dermatol 2004;29: 271–272.
- Hall VC, Liesegang TJ, Kostick DA, Lookingbill DP. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. Arch Dermatol 2003;139: 1083–1084.
- Mimouni D, Nousari CH, Cummins DL, Kouba DJ, David M, Anhalt GJ. Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris. J Am Acad Dermatol 2003;49: 1059–1062.
- Ahmed AR. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 2001;45: 679–690.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 18, 2005 - Issue 1